331 related articles for article (PubMed ID: 15966798)
1. Role of oncoproteomics in the personalized management of cancer.
Jain KK
Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in oncoproteomics.
Jain KK
Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
[TBL] [Abstract][Full Text] [Related]
4. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Applications of biochips: from diagnostics to personalized medicine.
Jain KK
Curr Opin Drug Discov Devel; 2004 May; 7(3):285-9. PubMed ID: 15216931
[TBL] [Abstract][Full Text] [Related]
7. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
9. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
10. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling in the age of cancer genomics.
Lin J; Li M
Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
[TBL] [Abstract][Full Text] [Related]
12. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
13. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
14. Genomics and proteomics: emerging technologies in clinical cancer research.
Chung CH; Levy S; Chaurand P; Carbone DP
Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
[TBL] [Abstract][Full Text] [Related]
15. Computational prediction of cancer-gene function.
Hu P; Bader G; Wigle DA; Emili A
Nat Rev Cancer; 2007 Jan; 7(1):23-34. PubMed ID: 17167517
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
17. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
18. Cancer biomarkers: current issues and future directions.
Jain KK
Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of glycomic approaches for the detection of cancer and other diseases.
Miyamoto S
Curr Opin Mol Ther; 2006 Dec; 8(6):507-13. PubMed ID: 17243486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]